|
Aug 13
|
Cencora Stock: Analyst Estimates & Ratings
|
|
Aug 13
|
The 5 Most Interesting Analyst Questions From Cencora’s Q2 Earnings Call
|
|
Aug 12
|
COR Q2 Deep Dive: Specialty Growth, International Headwinds, and Guidance Update
|
|
Aug 11
|
3 Reasons Growth Investors Will Love Cencora (COR)
|
|
Aug 10
|
Why You Might Be Interested In Cencora, Inc. (NYSE:COR) For Its Upcoming Dividend
|
|
Aug 8
|
Can Sustained Product Demand Drive CAH Stock Before Q4 Earnings?
|
|
Aug 7
|
ZBH Stock Gains On Q2 Earnings and Revenue Beat, '25 EPS View Up
|
|
Aug 7
|
STE Beats on Q1 Earnings and Revenues, Raises '26 Sales View
|
|
Aug 7
|
Cencora (COR) Reports Q3 Earnings Growth, Maintains US$0.55 Dividend
|
|
Aug 6
|
Mckesson lifts annual profit forecast on robust demand for specialty drugs
|
|
Aug 6
|
Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook
|
|
Aug 6
|
COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised
|
|
Aug 6
|
Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Aug 6
|
CRL Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 View
|
|
Aug 6
|
Cencora raises annual profit forecast on strong demand for specialty drugs
|
|
Aug 6
|
Cencora (COR) Q3 Earnings and Revenues Surpass Estimates
|
|
Aug 6
|
Cencora’s (NYSE:COR) Q2 Sales Top Estimates
|
|
Aug 6
|
Cencora: Fiscal Q3 Earnings Snapshot
|
|
Aug 6
|
Cencora Reports Fiscal 2025 Third Quarter Results
|
|
Aug 6
|
Podcasting Impact: Unprecedented Press Coverage of All Three National Drug Wholesaler Conferences Supporting Independent Pharmacy
|